Literature DB >> 72613

Properties of a P70 proteolytic factor of murine leukemia viruses.

Y Yoshinaka, R B Luftig.   

Abstract

Murine leukemia viruses, such as Rauscher leukemia virus (RLV), contain a proteolytic factor which becomes activated after detergent treatment of the virus. This factor specifically cleaves P70, the gag precursor polyprotein which is enriched for in preparations of immature virus core subparticles. The factor has been partially purified on Sephadex G-75 columns. It has a molecular weight of 10,000-12,000 daltons but does not coincide in elution position with the major peaks of the viral polypeptides p10 or p12. Under optimal conditions, that is 2% NP-40 (v/v), 10 mM DTT, (pH 7.2) and incubation for 16 hr at 22 degrees C, cleavage of labeled P70 occurs and increasing amounts of the four gag polypeptides p30, p15, p12 and p10 are obtained. The P70 cleavage activity is blocked by TLCK, TAME, CBZ-lysine and other lysyl-containing protease inhibitors. Further, the CBZ-lysine inhibition is reversible, while an inhibition by phenyl-methylsulfonyl fluoride (PMSF) is irreversible. These inhibition studies suggest that a similarity exists between the P70 proteolytic factor and some serine proteases, such as trypsin. The cleavage pattern of P70-rich immature cores treated with trypsin or chymotrypsin is different from that obtained with the P70 proteolytic factor. Thus murine leukemia virions apparently contain a unique, highly specific protease which is present in small amounts and cleaves P70.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72613     DOI: 10.1016/0092-8674(77)90271-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  40 in total

1.  Extracellular cleavage of the glycoprotein precursor of Rous sarcoma virus.

Authors:  R Klemenz; H Diggelmann
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

2.  Biochemical properties of p15-associated protease in an avian RNA tumor virus.

Authors:  K J Dittmar; K Moelling
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

3.  Mutational analysis of human immunodeficiency virus type 1 protease suggests functional homology with aspartic proteinases.

Authors:  D D Loeb; C A Hutchison; M H Edgell; W G Farmerie; R Swanstrom
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  Mechanical properties of murine leukemia virus particles: effect of maturation.

Authors:  Nitzan Kol; Micha Gladnikoff; David Barlam; Roni Z Shneck; Alan Rein; Itay Rousso
Journal:  Biophys J       Date:  2006-04-21       Impact factor: 4.033

Review 5.  Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes.

Authors:  W G Dougherty; B L Semler
Journal:  Microbiol Rev       Date:  1993-12

6.  Conditional human immunodeficiency virus type 1 protease mutants show no role for the viral protease early in virus replication.

Authors:  A H Kaplan; M Manchester; T Smith; Y L Yang; R Swanstrom
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

7.  Characterization of 40,000- and 25,000-dalton intermediate precursors to Rauscher murine leukemia virus gag gene products.

Authors:  R B Naso; W L Karshin; Y H Wu; R B Arlinghaus
Journal:  J Virol       Date:  1979-10       Impact factor: 5.103

8.  Retrovirus protease characterized as a dimeric aspartic proteinase.

Authors:  I Katoh; Y Ikawa; Y Yoshinaka
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

9.  Analysis of retroviral pol gene products with antisera raised against fusion proteins produced in Escherichia coli.

Authors:  N Tanese; M J Roth; S P Goff
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

10.  Analysis of secondary modifications of mouse mammary tumor virus proteins by two-dimensional gel electrophoresis.

Authors:  R Nusse; H Janssen; L de Vries; R Michalides
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.